Effect of Intravenous Calcium Gluconate on Intraoperative Blood Loss During Caesarean Section: A Randomised Controlled Trial at Nnewi

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202601807808004

Enrollment

220

Registered

2026-01-07

Start date

2026-01-18

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth

Interventions

Intravenous calcium gluconate

Sterile water for injection

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Pregnant women who are to have elective or emergency caesarean section

Exclusion criteria

Exclusion criteria: Antepartum haemorrhage History of bleeding disorder or use of anticoagulant therapy Blood transfusion prior to caesarean section Women on calcium channel blockers History of renal disease

Design outcomes

Primary

Measure	Time frame
Mean intraoperative blood loss during caesarean section	—

Secondary

Measure	Time frame
Need for additional uterotonics Need for blood transfusion	—

Countries

Nigeria

Contacts

Public ContactChiemezie Agbanu

Senior Registrar

agbanufrank@gmail.com+2348138611735

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026